HERSHBERG ROBERT
SEC CIK 1274139 · EDGAR
BoughtSold
Most active insiders at ADPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROBINS CHAD M | CEO, COB, Dir | — | $39.80M |
| 2 | ROBINS HARLAN S | CSO | — | $29.65M |
| 3 | BENZENO SHARON | Chief Commercial Ofc Imm Med | — | $14.69M |
| 4 | RUBINSTEIN JULIE | Pres, COO | — | $13.37M |
| 5 | LO FRANCIS | CHRO | — | $13.21M |
| 6 | PISKEL KYLE | CFO | — | $3.58M |
| 7 | NEUPERT PETER M | Dir | — | $3.14M |
| 8 | GRIFFIN MICHELLE RENEE | Dir | — | $2.00M |
| 9 | BOBULSKY SUSAN | Chief Commercial Off, MRD | — | $1.20M |
| 10 | HERSHBERG ROBERT | Dir | — | $1.12M |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-20 17:55 | 2026-08-18 | ADPT | Adaptive Biotechnologies Corp | HERSHBERG ROBERT | Dir | M - OptEx | $6.32 | +15.0K | 77.3K | +24% | +$94.8K |
| DM | 2026-08-20 17:55 | 2026-08-18 | ADPT | Adaptive Biotechnologies Corp | HERSHBERG ROBERT | Dir | S - Sale+OE | $24.40 | -30.7K | 46.7K | -40% | -$748.2K |
| 2026-06-22 16:32 | 2026-06-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +88.4K | 162.2K | +120% | $0 | |
| 2026-03-06 | 2026-03-04 | ADPT | Adaptive Biotechnologies Corp | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +15.6K | 62.3K | +33% | $0 | |
| 2025-12-12 | 2025-12-10 | ADPT | Adaptive Biotechnologies Corp | HERSHBERG ROBERT | Dir | S - Sale | $16.00 | -23.0K | 46.7K | -33% | -$367.5K | |
| D | 2025-06-23 | 2025-06-18 | RXRX | RECURSION PHARMACEUTICALS, INC. | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +22.0K | 73.7K | +43% | $0 |
| 2025-03-12 | 2025-03-12 | ADPT | Adaptive Biotechnologies Corp | HERSHBERG ROBERT | Dir | S - Sale | $7.59 | -53.0K | 69.7K | -43% | -$402.3K | |
| D | 2025-03-06 | 2025-03-04 | ADPT | Adaptive Biotechnologies Corp | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +15.4K | 122.7K | +14% | $0 |
| D | 2024-06-05 | 2024-06-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +13.1K | 51.7K | +34% | $0 |
| D | 2024-03-06 | 2024-03-04 | ADPT | Adaptive Biotechnologies Corp | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +31.3K | 107.3K | +41% | $0 |
| D | 2023-06-21 | 2023-06-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +12.6K | 38.6K | +48% | $0 |
| D | 2023-03-08 | 2023-03-06 | ADPT | Adaptive Biotechnologies Corp | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +14.8K | 76.0K | +24% | $0 |
| D | 2023-02-03 | 2023-02-02 | ADPT | Adaptive Biotechnologies Corp | HERSHBERG ROBERT | Dir | M - OptEx | $0.45 | +53.0K | 61.2K | +647% | +$23.9K |
| D | 2022-06-16 | 2022-06-14 | RXRX | RECURSION PHARMACEUTICALS, INC. | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +18.1K | 26.0K | +231% | $0 |
| D | 2022-06-13 | 2022-06-09 | FATE | FATE THERAPEUTICS INC | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +8,650 | 10.7K | +431% | $0 |
| 2022-06-06 | 2022-06-03 | FATE | FATE THERAPEUTICS INC | HERSHBERG ROBERT | Dir | S - Sale | $22.75 | -672 | 2,009 | -25% | -$15.3K | |
| D | 2022-01-28 | 2022-01-26 | ADPT | Adaptive Biotechnologies Corp | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +6,689 | 8,193 | +445% | $0 |
| 2022-01-05 | 2022-01-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +693 | 7,862 | +10% | $0 | |
| 2021-10-05 | 2021-10-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +572 | 7,169 | +9% | $0 | |
| 2021-07-06 | 2021-07-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +347 | 6,597 | +6% | $0 |
Purchase Sale Sale after option exercise All abbreviations